Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Agnosia 4Breast Neoplasms 3Squamous Cell Carcinoma of Head and Neck 2Pain, Postoperative 2Neoplasms 2Thyroid Nodule 1Thyroid Neoplasms 1Thyroid Diseases 1Rectal Neoplasms 1Pituitary Neoplasms 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Parathyroid Neoplasms 1Parathyroid Diseases 1Pain 1Opioid-Related Disorders 1Mucositis 1Mouth Neoplasms 1Intra-abdominal Cancer 1Ileus 1Goiter 1Diverticulosis, Colonic 1Diverticulitis, Colonic 1Constipation 1Colonic Neoplasms 1Chronic Pain 1Cancer Pain 1Brain Neoplasms 1

Interventions

Parathyroidectomy 5lutetium Lu 177 dotatate 1fluorocholine 1acetaminophen, codeine drug combination 1Tramadol 1Tablets 1Standard of Care 1Sodium Chloride 1Rubidium-82 1Nivolumab 1Magnetic Resonance Spectroscopy 1Denosumab 1Dacarbazine 1Control Groups 1Congresses as Topic 1Cinacalcet 1Capsules 1Bortezomib 1Blood Specimen Collection 1Acetaminophen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Parathyroid Neoplasms × Tramadol × Clear all
NCT03469310 2021-05-11

Minimizing Narcotic Analgesics After Endocrine Surgery

DHR Health Institute for Research and Development

Phase 4 Completed
126 enrolled
Head & Neck

Agnosia, Goiter, Opioid-Related Disorders, Parathyroid Diseases, Parathyroid Neoplasms, Thyroid Diseases, Thyroid Neoplasms, Thyroid Nodule

Data powered by HemOnc (CC BY 4.0) Colophon âš¡